| abstract |
(57) Summary A novel method for treating and / or inhibiting the development of prostate cancer, benign prostatic hyperplasia, prostatitis, acne, acne, seborrhea, or hirsutism and androgenic alopecia is a type 33α- The hydroxysteroid dehydrogenase inhibitor is used alone or in combination with other active pharmaceutical agents, such as a type 5 17β-hydroxysteroid dehydrogenase inhibitor. New inhibitors and pharmaceutical products are also disclosed. |